Marshall Wace
TARO

Marshall Wace’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Marshall Wace’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,500
Closed -$318K – 3098
2024
Q1 		$318K Buy
+7,500
New +$316K ﹤0.01% 2091
2023
Q1 		– Sell
-8,348
Closed -$242K – 3268
2022
Q4 		$242K Sell
8,348
-835
-9% -$24.8K ﹤0.01% 2640
2022
Q3 		$275K Sell
9,183
-1,178
-11% -$40.6K ﹤0.01% 2986
2022
Q2 		$374K Buy
+10,361
New +$395K ﹤0.01% 2934
2020
Q2 		– Sell
-9,224
Closed -$565K – 2034
2020
Q1 		$565K Buy
+9,224
New +$683K 0.01% 953
2019
Q4 		– Sell
-39,432
Closed -$2.98M – 2156
2019
Q3 		$2.98M Buy
39,432
+31,418
+392% +$2.55M 0.02% 650
2019
Q2 		$685K Buy
+8,014
New +$793K 0.01% 1016
2018
Q4 		– Sell
-7,007
Closed -$689K – 1865
2018
Q3 		$689K Buy
+7,007
New +$758K 0.01% 871
2016
Q2 		– Sell
-5,787
Closed -$829K – 1211
2016
Q1 		$829K Sell
5,787
-25,992
-82% -$3.69M 0.01% 756
2015
Q4 		$4.91M Buy
31,779
+2,322
+8% +$339K 0.05% 387
2015
Q3 		$4.21M Sell
29,457
-16,926
-36% -$2.37M 0.05% 323
2015
Q2 		$6.67M Buy
46,383
+9,354
+25% +$1.33M 0.09% 251
2015
Q1 		$5.22M Sell
37,029
-59,988
-62% -$9.23M 0.07% 308
2014
Q4 		$14.4M Buy
97,017
+63,889
+193% +$9.39M 0.19% 146
2014
Q3 		$5.1M Buy
33,128
+22,012
+198% +$3.31M 0.07% 286
2014
Q2 		$1.56M Buy
+11,116
New +$1.23M 0.02% 435

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Marshall Wace's TARO Position: Q2 2024 in Review

Marshall Wace sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 7,500 shares — an estimated $318K sold.

Marshall Wace first reported a position in TARO in Q2 2014 and held it in 16 quarters. The position peaked at $14.4M in Q4 2014. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Marshall Wace reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Marshall Wace sold 7,500 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $318K.
  • Marshall Wace first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 16 quarters.
  • Marshall Wace's Taro Pharmaceutical Industries Ltd. position peaked at $14.4M in Q4 2014.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.